サンバイオの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/01/11 | 1,312 | 1,330 | 1,311 | 1,325 | +13 | +1% | 135,300 |
| 2017/01/10 | 1,321 | 1,329 | 1,305 | 1,312 | ±0 | ±0% | 137,700 |
| 2017/01/06 | 1,338 | 1,345 | 1,309 | 1,312 | -27 | -2% | 205,900 |
| 2017/01/05 | 1,293 | 1,342 | 1,292 | 1,339 | +53 | +4.1% | 256,400 |
| 2017/01/04 | 1,303 | 1,319 | 1,286 | 1,286 | -1 | -0.1% | 245,000 |
| 2016/12/30 | 1,253 | 1,292 | 1,253 | 1,287 | +25 | +2% | 198,000 |
| 2016/12/29 | 1,259 | 1,270 | 1,248 | 1,262 | +2 | +0.2% | 300,200 |
| 2016/12/28 | 1,267 | 1,283 | 1,254 | 1,260 | -10 | -0.8% | 222,600 |
| 2016/12/27 | 1,270 | 1,298 | 1,261 | 1,270 | -1 | -0.1% | 327,600 |
| 2016/12/26 | 1,232 | 1,272 | 1,230 | 1,271 | +39 | +3.2% | 459,100 |
| 2016/12/22 | 1,225 | 1,246 | 1,205 | 1,232 | -53 | -4.1% | 643,200 |
| 2016/12/21 | 1,330 | 1,332 | 1,281 | 1,285 | -55 | -4.1% | 598,800 |
| 2016/12/20 | 1,329 | 1,342 | 1,327 | 1,340 | +19 | +1.4% | 217,400 |
| 2016/12/19 | 1,333 | 1,353 | 1,320 | 1,321 | -18 | -1.3% | 346,200 |
| 2016/12/16 | 1,359 | 1,360 | 1,331 | 1,339 | -17 | -1.3% | 185,500 |
| 2016/12/15 | 1,388 | 1,389 | 1,345 | 1,356 | -17 | -1.2% | 249,100 |
| 2016/12/14 | 1,386 | 1,387 | 1,361 | 1,373 | -13 | -0.9% | 128,500 |
| 2016/12/13 | 1,350 | 1,387 | 1,342 | 1,386 | +29 | +2.1% | 189,500 |
| 2016/12/12 | 1,385 | 1,390 | 1,345 | 1,357 | -28 | -2% | 271,000 |
| 2016/12/09 | 1,330 | 1,393 | 1,330 | 1,385 | +31 | +2.3% | 234,400 |
| 2016/12/08 | 1,384 | 1,387 | 1,325 | 1,354 | -39 | -2.8% | 355,300 |
| 2016/12/07 | 1,420 | 1,420 | 1,388 | 1,393 | -22 | -1.6% | 166,500 |
| 2016/12/06 | 1,415 | 1,433 | 1,408 | 1,415 | -5 | -0.4% | 100,200 |
| 2016/12/05 | 1,430 | 1,437 | 1,409 | 1,420 | +6 | +0.4% | 194,300 |
| 2016/12/02 | 1,449 | 1,455 | 1,405 | 1,414 | -36 | -2.5% | 216,400 |
| 2016/12/01 | 1,457 | 1,480 | 1,436 | 1,450 | -15 | -1% | 197,200 |
| 2016/11/30 | 1,420 | 1,478 | 1,416 | 1,465 | +45 | +3.2% | 295,700 |
| 2016/11/29 | 1,388 | 1,443 | 1,386 | 1,420 | +22 | +1.6% | 128,700 |
| 2016/11/28 | 1,405 | 1,413 | 1,384 | 1,398 | +1 | +0.1% | 91,600 |
| 2016/11/25 | 1,415 | 1,415 | 1,381 | 1,397 | -19 | -1.3% | 142,900 |
| 2016/11/24 | 1,430 | 1,434 | 1,400 | 1,416 | +2 | +0.1% | 163,100 |
| 2016/11/22 | 1,400 | 1,426 | 1,360 | 1,414 | -2 | -0.1% | 411,000 |
| 2016/11/21 | 1,473 | 1,491 | 1,413 | 1,416 | -83 | -5.5% | 447,300 |
| 2016/11/18 | 1,525 | 1,533 | 1,487 | 1,499 | -19 | -1.3% | 221,100 |
| 2016/11/17 | 1,473 | 1,518 | 1,462 | 1,518 | +38 | +2.6% | 259,100 |
| 2016/11/16 | 1,458 | 1,485 | 1,448 | 1,480 | +11 | +0.7% | 196,200 |
| 2016/11/15 | 1,385 | 1,469 | 1,375 | 1,469 | +85 | +6.1% | 345,800 |
| 2016/11/14 | 1,377 | 1,408 | 1,372 | 1,384 | +9 | +0.7% | 90,400 |
| 2016/11/11 | 1,412 | 1,413 | 1,362 | 1,375 | -18 | -1.3% | 95,500 |
| 2016/11/10 | 1,367 | 1,420 | 1,362 | 1,393 | +86 | +6.6% | 235,700 |
| 2016/11/09 | 1,369 | 1,385 | 1,235 | 1,307 | -63 | -4.6% | 414,400 |
| 2016/11/08 | 1,400 | 1,403 | 1,357 | 1,370 | -25 | -1.8% | 107,500 |
| 2016/11/07 | 1,344 | 1,397 | 1,329 | 1,395 | +21 | +1.5% | 307,300 |
| 2016/11/04 | 1,310 | 1,378 | 1,301 | 1,374 | +38 | +2.8% | 297,900 |
| 2016/11/02 | 1,336 | 1,363 | 1,300 | 1,336 | -16 | -1.2% | 305,400 |
| 2016/11/01 | 1,399 | 1,402 | 1,348 | 1,352 | -57 | -4% | 327,100 |
| 2016/10/31 | 1,417 | 1,422 | 1,397 | 1,409 | -9 | -0.6% | 126,600 |
| 2016/10/28 | 1,444 | 1,461 | 1,394 | 1,418 | -22 | -1.5% | 173,300 |
| 2016/10/27 | 1,450 | 1,467 | 1,430 | 1,440 | +30 | +2.1% | 197,600 |
| 2016/10/26 | 1,392 | 1,423 | 1,392 | 1,410 | +11 | +0.8% | 106,500 |
2051～
2100
件表示中 / 2479件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サンバイオ | 322,000円 | - | - | 0.00% | - | 149.14倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ツムラ | 335,500円 | +3.8% | -19.9% | 4.05% | 10.97倍 | 0.84倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 日本新薬 | 355,000円 | +8.0% | -15.3% | 3.49% | 9.97倍 | 0.97倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ペプチド | 169,800円 | +5.0% | +1.5% | 0.00% | 14.52倍 | 3.86倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| ジーエヌアイ | 406,000円 | +21.7% | +999.9% | 0.00% | 17.01倍 | 5.63倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム
